(August 25, 2014- New York, NY)-- The Autism Science Foundation, a not-for-profit organization dedicated to funding autism research, today announced that Dr. Alycia Halladay will join the organization as Chief Science Officer. The announcement was made by Autism Science Foundation president Alison Singer.
“Dr. Halladay is the perfect person to lead our growing science department” said Singer. “She has extensive experience in all aspects of autism research, as well as a deep understanding of how to maximize investment in research to provide the best outcomes for families. I could not be more thrilled to have her as part of our executive team.”
Halladay previously served as the Senior Director of Clinical and Environmental Sciences and Interim Head of the Etiology Portfolio at Autism Speaks. Prior to joining Autism Speaks, she was Associate Director for Research at the National Alliance for Autism Research (NAAR). While at NAAR and Autism Speaks, she worked across all areas of autism science, directing or managing portfolios relating to risk factors, diagnosis, and treatment of ASDs. In addition, she led activities relating to family services, communications, awareness, and advocacy. She has a Ph.D. in psychology and behavioral neuroscience from Rutgers University and completed a post-doctoral fellowship in the department of pharmacology and toxicology at Rutgers where she later joined as faculty and currently holds an adjunct position. She has participated as a guest editor for a number of journals including Neurotoxicology, Autism Research, Brain Research and Gastroenterology and has served on grant review panels for the CDC and the NJ Governor’s Council for ASD.
“I am proud and honored to lead the growing science program at the Autism Science Foundation” said Halladay. “This is an exciting and important time for autism research, and I look forward to working with ASF to continue and also expand its scientific contributions.”
In its five years of operations, the Autism Science Foundation has funded over $1.6 million in grants including pre and postdoctoral fellowships, medical school gap year research fellowships, 3-year early career awards, treatment grants, undergraduate summer research funding, research enhancement mini-grants and travel scholarships to enable stakeholders to attend the annual International Meeting for Autism Research (IMFAR).
“Autism Science Foundation’s research programs have grown consistently year after year and now need full time leadership to oversee their continued expansion”, said Dr. Matthew State, chair of ASF’s Scientific Advisory Board and Chair of the Department of Psychiatry at the University of California in San Francisco. “Alycia is a highly respected autism scientist and has exactly the right experience to lead ASF into the next phase of its growth.”
Dr. Halladay will begin work with the foundation on September 8, 2014.
Founded in 2009, Autism Science Foundation (ASF) is a 501(c) (3) public charity. Its mission is to support autism research by providing funding to scientists and organizations conducting autism research. ASF also provides information about autism to the general public and serves to increase awareness of autism spectrum disorders and the needs of individuals and families affected by autism. To learn more about the Autism Science Foundation or to make a donation visit www.autismsciencefoundation.org.
Autism Science Foundation